ANI announced the launch of Fenofibrate Capsules, the generic version of Kowa’s Lipofen.
Lipofen is a peroxisome proliferator receptor alpha (PPARα) activator indicated as an adjunct to diet for the reduction of LDL-C, Total-C, TG and Apo B, and the increase of HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia and for treatment of adult patients with severe hypertriglyceridemia.
Fenofibrate Capsules are available in 50mg and 150mg strengths in 90-count bottles.
For more information call (800) 434-1121 or visit AniPharmaceuticals.com.
